DUBLIN--(BUSINESS WIRE)--The "Research Antibodies and Reagents Market by Product (Reagent [Sample Preparation (Media, Probe, Buffer), Antibody Production Reagent], Antibody [Type, Source, Research Area]), Technology (Western Blot, ELISA), Application, End User - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The Global Research Antibodies and Reagents Market is Expected to Grow at a CAGR of 6% from 2019 to 2025 to Reach $14.56 Billion by 2025
The factors such as rising proteomics & genomic research studies, increase in the funding for research activities, and growing industry-academia collaborations - are driving the growth of the global research antibodies and reagents market.
The reagents segment is estimated to command the largest share of the global research antibodies and reagents market in 2019 and expected to continue its dominance during the forecast period mainly due to increasing use of reagents and kits in research assays and techniques.
The research antibodies and reagents market for the pharmaceutical and biotechnology industry (end user segment) segment is estimated to command the largest share of the global market in 2019. This is attributed to rising adoption of research antibodies & reagents in the proteomics research and drug discovery programs with the growing focus of industry vendors on the development of innovative therapeutic drugs for chronic diseases.
An in-depth analysis of the geographical scenario of the research antibodies & reagents market provides detailed qualitative and quantitative insights about the five major geographies along with the coverage of major countries in each region.
North America dominated the global research antibodies and reagents market in 2019, followed by Europe, and Asia-Pacific region. The large share of this region is mainly attributed to the availability of new technologies in the region, increasing research activities to assist the development of personalized medicine, and the direct presence of the key players.
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Market Insights
4.2. Market Dynamics
22.214.171.124. Rising Proteomics and Genomics Research Studies
126.96.36.199. Increase in the Funding for Research Activities
188.8.131.52. Growing Industry-Academia Collaboration
184.108.40.206. High Cost and Time Related to Identification and Development of Potential Antibodies
220.127.116.11. Rising Demand for Protein Therapeutics and Personalized Medicines
18.104.22.168. Rising Investment and Focus on Stem-Cell Research
22.214.171.124. Rising Need for New Biomarker Identification
126.96.36.199. Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets
188.8.131.52. Issues Related to Quality and Stability of Research Antibodies
184.108.40.206. Intense Pricing Pressure on Leading Players
5. Research Antibodies and Reagents Market, by Product
5.2.1. Sample Preparation Reagents
220.127.116.11. Media and Serum
18.104.22.168. Stains and Dyes
5.2.2. Antibody Production Reagents
5.2.3. Other Research Reagents
5.3.1. Antibodies Market, by Type
22.214.171.124. Primary Antibody
126.96.36.199. Secondary Antibody
5.3.2. Antibodies Market, by Production Type
188.8.131.52. Monoclonal Antibody
184.108.40.206. Polyclonal Antibody
220.127.116.11. Antibody Fragments
5.3.3. Antibody Market, by Source
18.104.22.168. Other Sources
5.3.4. Antibodies Market, by Research Area
22.214.171.124. Infectious Diseases
126.96.36.199. Cardiovascular Disease
188.8.131.52. Stem Cell Research
184.108.40.206. Other Research Areas
6. Research Antibodies and Reagents Market, by Technology
6.2 Western Blot
6.4. Enzyme-Linked Immunosorbent Assay
6.5. Multiplex Immunosorbent Assay
6.6. Flow Cytometry
6.8. Immunoprecipitation (IP)
6.9. Other Technologies
7. Research Antibodies and Reagents Market, by Application
7.3. Drug Discovery and Development
8. Research Antibodies and Reagents Market, by End User
8.2. Pharmaceutical and Biotechnology Industry
8.3. Academics and Research Institutes
8.4. Contract Research Organizations
9. Research Antibodies and Reagents Market, by Geography
9.2. North America
9.5. Latin America
9.6. Middle East & Africa
10. Competitive Landscape
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2018)
11. Company Profiles
11.1. GE Healthcare
11.1.1. Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.2. Merck KGaA
11.3. Thermo Fisher Scientific Inc.
11.4. F. Hoffmann-La Roche Ltd
11.5. Rockland Immunochemicals Inc.
11.6. Johnson & Johnson (J&J)
11.7. Eli Lilly and Company
11.8. Teva Pharmaceutical Industries Limited
11.9. Abcam plc
11.10. Agilent Technologies, Inc.
11.11. Cell Signaling Technology, Inc.
11.12. Becton Dickinson and Company
11.13. Danaher Corporation
11.15. PerkinElmer, Inc.
11.16. Genscript Biotech Corporation
11.17. Bio-Techne Corporation
11.18. Bio-Rad Laboratories, Inc.
11.19. Santa Cruz Biotechnology, Inc.
11.20. BioLegend, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/mrnreu